Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors
- PMID: 40516152
- PMCID: PMC12276996
- DOI: 10.1016/j.oraloncology.2025.107337
Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors
Abstract
Purpose: This study aims to identify radiomic features from contrast-enhanced CT (CECT) scans that differentiate osteoradionecrosis (ORN) from normal mandibular bone in head and neck cancer (HNC) patients treated with radiotherapy (RT).
Materials and methods: CECT images from 150 patients with confirmed ORN diagnosis (2008-2018) at MD Anderson Cancer Center (MDACC) were analyzed (80 % train, 20 % test). Radiomic features were extracted using PyRadiomics from manually segmented ORN regions and automated contralateral healthy mandible regions. Correlation analysis (r > 0.95) reduced features for model training. A random Forest (RF) classifier with Recursive Feature Elimination identified discriminative features. Explainability was assessed using SHapley Additive exPlanations (SHAP) analysis on the 20 most important features identified by the trained RF classifier.
Results: Of the 1316 radiomic features extracted, 810 features were excluded for high collinearity. From a set of 506 pre-selected radiomic features, 67 were optimal for RF classification, yielding 88% accuracy and a ROC AUC of 0.96. The model well calibrated (Log Loss 0.296, ECE 0.125) and achieved an accuracy of 88% and a ROC AUC of 0.96. The SHAP analysis revealed that higher values of Wavelet-LLH First order Mean and Median were associated with ORN of the jaw (ORNJ). Conversely, higher Exponential GLDM Dependence Entropy and lower Square First-order Kurtosis were more characteristic of normal mandibular tissue.
Conclusion: This study successfully developed a CECT-based radiomics model for differentiating ORNJ from healthy mandibular tissue in HNC patients after RT. Future work will focus on detecting subclinical ORNJ regions to guide earlier interventions.
Copyright © 2025. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: K.K.B. holds a licensing agreement with RaySearch Laboratories AB. C.D.F. declares financial interests with the National Institutes of Health, Elekta AB, Kallsio Inc., Siemens Healthineers/Varian, Philips Medical Systems, and licensing royalties from unrelated technologies via Kallsio Inc. Additionally, serves on committees for professional societies including The American Association for Physicists in Medicine, among others. K.H. reports funding and institutional support from various sources, including grants for studies related to dysphagia and collaborative projects at MD Anderson. Additionally, involvement in multiple professional and educational conferences and societies. K.A.W. is supported by a fellowship from the Image-Guided Cancer Therapy T32 Training Program (T32CA261856). A.C.M. received salary and material support via NIH/NIDCR grants (K12CA088084, R21DE031082, K01DE030524) and philanthropic support from the MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer Oropharyngeal Cancer Research Program. M.A.N funded by NIH/NIDCR R03 grant (1R03DE033550-01). S.K. supported by NIH Grants #8-9598u and #0384u. L.v.D. received funding and salary support from the KWF Dutch Cancer Society (Young Investigator Grant, KWF-13529) and NWO ZonMw (VENI Grant, NWO-09150162010173), among others. D.T.A.F. funded through R01CA195524. All other authors have nothing to declare.
Figures






Update of
-
Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors.medRxiv [Preprint]. 2024 Sep 12:2024.09.11.24313485. doi: 10.1101/2024.09.11.24313485. medRxiv. 2024. Update in: Oral Oncol. 2025 Aug;167:107337. doi: 10.1016/j.oraloncology.2025.107337. PMID: 39314948 Free PMC article. Updated. Preprint.
References
MeSH terms
Grants and funding
- T32 CA261856/CA/NCI NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- R01 DE025248/DE/NIDCR NIH HHS/United States
- R03 DE033550/DE/NIDCR NIH HHS/United States
- U01 DE032168/DE/NIDCR NIH HHS/United States
- K01 DE030524/DE/NIDCR NIH HHS/United States
- R01 CA195524/CA/NCI NIH HHS/United States
- R01 CA258827/CA/NCI NIH HHS/United States
- F31 DE031502/DE/NIDCR NIH HHS/United States
- R01 CA257814/CA/NCI NIH HHS/United States
- R01 DE028290/DE/NIDCR NIH HHS/United States
- R21 DE031082/DE/NIDCR NIH HHS/United States
- K12 CA088084/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous